Logically a disease with the inflammatory features of rheumatoid arthritis can be best treated with agents which exert an anti-inflammatory effect. The usefulness of analgesics devoid of anti-inflammatory properties is unclear, even though they are commonly prescribed or otherwise obtained by patients.
The present study was designed to answer three principal questions: What benefits do patients with RA most hope to obtain from the drugs they receive for their arthritis? What role do hospital doctors assign to simple analgesics in the management of RA? Are these views shared by their patients?
Patients and methods
The survey was conducted at four London teaching hospitals. Nine consultant rheumatologists and 12 registrars completed a questionnaire which asked whether the respondents considered that simple analgesics were worth prescribing in RA There were 120 patients in the survey, and all identified one treatment objective which they considered the most important. Some could not distinguish between objectives which they considered of less importance (Table 1) . Almost half (47%) gave first priority to pain relief, but reduction of stiffness (10%) and swelling (2%) were not viewed as highly desirable benefits. This distribution was significantly It has been suggested that simple analgesics are ineffective3 in RA, and in some accounts of treatment they are not mentioned. 4 On the other hand it has been argued that the addition of centrally acting analgesics to the peripherally acting antiinflammatory drugs is rational5 and that if patients
are not given them they will obtain them.6
Most of the rheumatologists in our survey prescribed analgesics sometimes, and this was confirmed by the patients' accounts of initial analgesic prescribing. The analgesics favoured by the rheumatologists matched those taken by the patients, although Distalgesic was taken more frequently than might have been anticipated from the rheumatologists' replies.
One disturbing feature of our study was the frequent use of analgesics without the knowledge of the rheumatologists. This may have reflected failures of communication, but it is also possible that the patients' aims and expectations differed from those of the doctors. The survey of therapeutic objectives as perceived by the patients left no doubt that pain relief was by far the most desired end point, and half those taking both anti-inflammatory and simple analgesics thought the latter more effective. However, one cannot conclude that simple analgesics are more or less effective than anti-inflammatory drugs from such data. Pain relief is a predictable benefit of anti-inflammatory treatment, and in one study analgesics were found to be less effective than anti-inflammatory doses of salicylates in RA. 
